Welcome to LookChem.com Sign In|Join Free
  • or
p-iodobenzoate de p-nitrophenol is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

97028-77-8

Post Buying Request

97028-77-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

97028-77-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 97028-77-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,7,0,2 and 8 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 97028-77:
(7*9)+(6*7)+(5*0)+(4*2)+(3*8)+(2*7)+(1*7)=158
158 % 10 = 8
So 97028-77-8 is a valid CAS Registry Number.

97028-77-8Relevant academic research and scientific papers

4-Nitrophenyl activated esters are superior synthons for indirect radiofluorination of biomolecules

Haskali, Mohammad B.,Farnsworth, Ashleigh L.,Roselt, Peter D.,Hutton, Craig A.

, p. 919 - 922 (2020/09/15)

Indirect radiolabelling has for a long time been the mainstay strategy for radiofluorination of biomolecules. Acylation of biomolecules through the use of an 18F-labelled activated ester is a standard method for indirect radiolabelling. However, the preparation of 18F-labelled activated esters is typically a complex and multistep procedure. Herein, we describe the use of 4-nitrophenyl (PNP) activated esters to rapidly prepare 18F-labelled acylation synthons in one step. Furthermore, we present a comparative study of PNP activated esters and the commonly utilised 2,3,5,6-tetrafluorphenyl (TFP) activated esters under direct radiofluorination conditions and demonstrate their relative acylation behaviour. We demonstrate the superiority of PNP esters under direct radiofluorination conditions with favourable acylation kinetics.

Agents for diagnosing and treating melanomas, aromatic halogenated derivatives usable as such agents and their preparation

-

, (2008/06/13)

STR1 The invention concerns agents for diagnosing and treating malignant melanomas, of general formula (I), in which X denotes a hydrogen or halogen atom, Y denotes a Z--CONH--, Z--O--, Z--S(O)--n1 group, n1 being equal to 0,1,2 or 3

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 97028-77-8